EP1007563A4 - Hm74a receptor - Google Patents
Hm74a receptorInfo
- Publication number
- EP1007563A4 EP1007563A4 EP98930215A EP98930215A EP1007563A4 EP 1007563 A4 EP1007563 A4 EP 1007563A4 EP 98930215 A EP98930215 A EP 98930215A EP 98930215 A EP98930215 A EP 98930215A EP 1007563 A4 EP1007563 A4 EP 1007563A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- hm74a receptor
- hm74a
- receptor
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Physical Education & Sports Medicine (AREA)
- Pain & Pain Management (AREA)
- Pulmonology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Psychology (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Nutrition Science (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US4948097P | 1997-06-12 | 1997-06-12 | |
US49480P | 1997-06-12 | ||
PCT/US1998/012386 WO1998056820A1 (en) | 1997-06-12 | 1998-06-12 | Hm74a receptor |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1007563A1 EP1007563A1 (en) | 2000-06-14 |
EP1007563A4 true EP1007563A4 (en) | 2003-04-16 |
Family
ID=21960050
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP98930215A Withdrawn EP1007563A4 (en) | 1997-06-12 | 1998-06-12 | Hm74a receptor |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1007563A4 (en) |
JP (1) | JP2002508660A (en) |
AU (1) | AU7966098A (en) |
WO (1) | WO1998056820A1 (en) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7119190B2 (en) | 1997-04-14 | 2006-10-10 | Arena Pharmaceuticals, Inc. | Endogenous and non-endogenous versions of human G protein-coupled receptors |
US6555339B1 (en) | 1997-04-14 | 2003-04-29 | Arena Pharmaceuticals, Inc. | Non-endogenous, constitutively activated human protein-coupled receptors |
GB9807722D0 (en) * | 1998-04-08 | 1998-06-10 | Smithkline Beecham Plc | Novel compounds |
AUPP438598A0 (en) | 1998-06-29 | 1998-07-23 | Garvan Institute Of Medical Research | NPY-Y7 receptor gene |
GB9917628D0 (en) * | 1999-07-27 | 1999-09-29 | Smithkline Beecham Plc | Novel compounds |
CA2390547A1 (en) * | 1999-11-17 | 2001-05-25 | Arena Pharmaceuticals, Inc. | Endogenous and non-endogenous versions of human g protein-coupled receptors |
EP1278838A2 (en) * | 2000-03-27 | 2003-01-29 | PE Corporation (NY) | Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
EP1272631A2 (en) * | 2000-04-05 | 2003-01-08 | Bayer Aktiengesellschaft | Regulation of human hm74-like g protein coupled receptor |
AU2001267898A1 (en) * | 2000-07-04 | 2002-01-14 | Takeda Chemical Industries Ltd. | Novel g protein-coupled receptor protein and dna thereof |
WO2002004624A1 (en) * | 2000-07-07 | 2002-01-17 | Takeda Chemical Industries, Ltd. | Novel g protein-coupled receptor protein and dna thereof |
JP2004505648A (en) * | 2000-08-18 | 2004-02-26 | ノバルティス アクチエンゲゼルシャフト | Inflammation-related G protein-coupled receptor |
CA2440058A1 (en) * | 2001-03-07 | 2002-09-19 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy27 |
AU2002242910A1 (en) * | 2001-04-11 | 2002-10-28 | Glaxo Group Limited | Medicaments which are modulators of hm74 and/or hm74a activity |
US6902902B2 (en) | 2001-11-27 | 2005-06-07 | Arena Pharmaceuticals, Inc. | Human G protein-coupled receptors and modulators thereof for the treatment of metabolic-related disorders |
US7189524B1 (en) | 2002-11-25 | 2007-03-13 | Amgen, Inc. | Receptor ligands and methods of modulating receptors |
EP1597586A2 (en) * | 2003-02-13 | 2005-11-23 | Bayer HealthCare AG | Diagnostics and therapeutics for diseases associated with hm74 |
EP1597587A2 (en) | 2003-02-17 | 2005-11-23 | Bayer HealthCare AG | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) |
WO2004083388A2 (en) | 2003-03-14 | 2004-09-30 | Bristol-Myers Squibb Company | Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74 |
BRPI0506792A (en) * | 2004-02-20 | 2007-05-22 | Aventis Pharma Inc | furosemide derivatives as hm74 modulators and their use in treating inflammation |
CN1929833A (en) * | 2004-02-20 | 2007-03-14 | 安万特药物公司 | Oxydecahydronaphthalene modulators of HM74 |
US20060078916A1 (en) * | 2004-08-27 | 2006-04-13 | Luc Aguilar | HM74 and HM74a in cuboidal endothelial cells as associated with inflammation |
CA2589483C (en) | 2004-12-03 | 2013-10-29 | Schering Corporation | Substituted piperazines as cb1 antagonists |
EP1901731B1 (en) | 2005-06-28 | 2011-03-02 | Merck Sharp & Dohme Corp. | Niacin receptor agonists, compositions containing such compounds and methods of treatment |
CA2628401A1 (en) * | 2005-12-07 | 2007-06-14 | Boehringer Ingelheim International Gmbh | Treatment and diagnostics of inflammatory diseases |
CA2637565A1 (en) | 2006-01-18 | 2007-07-26 | Schering Corporation | Cannibinoid receptor modulators |
BRPI0713619A2 (en) | 2006-06-23 | 2013-01-15 | Incyte Corp | compound or prodrug or pharmaceutically acceptable salt thereof, composition, and use of the compound. |
ATE486874T1 (en) | 2006-06-23 | 2010-11-15 | Incyte Corp | PURINONE DERIVATIVES AS HM74A AGONISTS |
RU2010102478A (en) | 2007-06-28 | 2011-08-10 | Интэрвэт Интэрнэшнл Б.Ф. (NL) | SUBSTITUTED PIPERASINS AS CB1 ANTAGONISTS |
-
1998
- 1998-06-12 EP EP98930215A patent/EP1007563A4/en not_active Withdrawn
- 1998-06-12 JP JP50331999A patent/JP2002508660A/en active Pending
- 1998-06-12 WO PCT/US1998/012386 patent/WO1998056820A1/en not_active Application Discontinuation
- 1998-06-12 AU AU79660/98A patent/AU7966098A/en not_active Abandoned
Non-Patent Citations (4)
Title |
---|
LEE D K ET AL: "DISCOVERY AND MAPPING OF TEN NOVEL G PROTEIN-COUPLED RECEPTOR GENES", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER SCIENCE PUBLISHERS, BARKING, GB, vol. 275, no. 1, 2001, pages 83 - 91, XP004307114, ISSN: 0378-1119 * |
NOMURA H ET AL: "Human mRNA for HM74", EMBL ACCESSION NUMBER D10923, 16 July 1992 (1992-07-16), XP002212023 * |
See also references of WO9856820A1 * |
WISE A ET AL: "Molecular identification of high and low affinity receptors for nicotinic acid", JBC PAPERS IN PRESS, - 9 January 2003 (2003-01-09), XP002231659, Retrieved from the Internet <URL:www.jbc.org/cgi/reprint/M210695200v1> [retrieved on 20030218] * |
Also Published As
Publication number | Publication date |
---|---|
WO1998056820A1 (en) | 1998-12-17 |
EP1007563A1 (en) | 2000-06-14 |
JP2002508660A (en) | 2002-03-19 |
AU7966098A (en) | 1998-12-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1007563A4 (en) | Hm74a receptor | |
DE59803915D1 (en) | Bandwaage | |
DE59806556D1 (en) | Fmcw-sensor | |
HK1029035A1 (en) | Teeth-cleansing means | |
GB9710773D0 (en) | Cytofunnel arrangement | |
DE59805100D1 (en) | Containerbrücke | |
DE59803341D1 (en) | Handhobelmaschine | |
DE59808840D1 (en) | Compoundpumpe | |
DE59811907D1 (en) | Transponder-system | |
DE59803148D1 (en) | Dimensionsstabile thermoplastische formmassen | |
DE69801658D1 (en) | Polyurethanhartschaumstoffe | |
EP0973800A4 (en) | Novel receptor | |
DE69715258D1 (en) | Präzisionshydraulikfutter | |
GB9718143D0 (en) | Airbags | |
GB9718142D0 (en) | Airbags | |
DE59806884D1 (en) | Dexamethason-gel | |
GB9708589D0 (en) | Seurity means | |
CA81694S (en) | Tape-rule | |
CA79884S (en) | Moniitor | |
DE59811113D1 (en) | Laryngoskop | |
DE59809032D1 (en) | Telephonsystem | |
CA80910S (en) | Aeroglisseur | |
CA80851S (en) | Thermomter | |
CA80915S (en) | Elbow-rest | |
CA82333S (en) | Remorque |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20000112 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): BE CH DE DK FR GB IT LI NL |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 20030305 |
|
17Q | First examination report despatched |
Effective date: 20030527 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040610 |